South & Central America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 – Regional Analysis – by Service Type (Lyophilization Cycle Development, Clinical Manufacturing, Commercial Manufacturing, and Freeze-Drying Analytical Services

South & Central America Lyophilization Services for Biopharmaceuticals Market Forecast to 2028 – Regional Analysis – by Service Type (Lyophilization Cycle Development, Clinical Manufacturing, Commercial Manufacturing, and Freeze-Drying Analytical Services) and End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Other)

The South & Central America lyophilization services for biopharmaceuticals market was valued at US$ 70.02 million in 2023 and is expected to reach US$ 104.37 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2023 to 2028.

Rapid Growth in Contract Manufacturing and Lyophilization Services Fuels the South & Central America Lyophilization Services for Biopharmaceuticals Market

The biopharmaceuticals market continues to expand across the world, which can be the primary growth driver for the pharmaceutical industry. Biopharmaceutical parenteral manufacturing has expanded recently as more therapeutic biologics have been approved. Biotechnology companies outsource from contract manufacturing organizations (CMOs) to meet their fill-and-finish needs and reduce the risk of microbial contamination. Biopharma companies are dependent on contract manufacturing organizations (CMOs) to provide capacity and capabilities as needed; in some cases, CMOs provide a great deal of a company’s production.

Setting up in-house lyophilization capabilities and operations requires specialized equipment and expertise, which is an expensive and time-consuming. However, outsourcing is cheaper and increases the efficiency of manufacturing processes. Additionally, it allows biotechnology companies to redirect resources to other areas. Thus, drug developers and biopharmaceutical companies outsource such operations to CMOs to save overall production and yield cost. A few years ago, the CMO industry was a niche service market, offering additional manufacturing capacity or specific services to biotechnology companies. Now, many biotechnology companies outsource various services, from early-stage drug development to commercial-scale manufacturing. As the biotechnology industry is shifting from large-scale production to niche and targeted therapies (personalized medicine), the demand for flexible operational capabilities, production scales, and multiple-product operations is rising. Owing to all these factors, the inclination toward CMOs is growing. Thus, the rising capability and availability of biopharma CMOs fuel the South & Central America lyophilization service for biopharmaceuticals market growth.

South & Central America Lyophilization Services for Biopharmaceuticals Market Overview

South and Central America region consist of Brazil, Argentina, and the Rest of the South and Central America. Brazil is expected to have a major market share in this region. The market is likely to have good growth opportunities owing to the huge investment for research and development in the pharmaceutical and biopharmaceutical industry. In addition, the collaboration with foreign authorities and organizations is likely to demand the lyophilization services in the countries.

South & Central America Lyophilization Services for Biopharmaceuticals Market Revenue and Forecast to 2028 (US$ Mn)

South & Central America Lyophilization Services for Biopharmaceuticals Market Segmentation

The South & Central America lyophilization services for biopharmaceuticals market is segmented service type, end user, and country.

Based on service type, the South & Central America lyophilization services for biopharmaceuticals market is segmented into lyophilization cycle development, clinical manufacturing, commercial manufacturing, and freeze drying analytical services. The commercial manufacturing segment held the largest market share in 2023.

Based on end-user, the South & Central America lyophilization services for biopharmaceuticals market is segmented into pharmaceutical & biotechnology companies, research institutes, and other. The pharmaceutical & biotechnology companies segment held the largest market share in 2023.

Based on country, the South & Central America lyophilization services for biopharmaceuticals market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America lyophilization services for biopharmaceuticals market share in 2023.

ABB, Azbil Corporation, Curia Global Inc, Grifols S.A., Jubilant HollisterStier LLC., and OPTIMA are some of the leading companies operating in the South & Central America lyophilization services for biopharmaceuticals market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America lyophilization services for biopharmaceuticals market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in South & Central America lyophilization services for biopharmaceuticals market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.